ELEV Overview
Upcoming Projects (ELEV)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ELEV)
-
Discussing the potential of EO-3021, a Claudin 18.2 ADC), and the Phase I trial in gastric (GC), gastroesophageal junction (GEJ), and pancreatic cancers.
Tickers: ELEV, ALPMY
Executed On: Nov 14, 2024 at 02:00 PM EST -
Discussing novel therapeutics to treat gastric cancer/GEJ Adenocarcinoma, including Leap Therapeutics' DKN-01 (anti-DKK1) on top of PD-1 and chemo, as well as Claudin 18.2 (Zolbetuximab from Astellas, & SYSA1801 from Elevation Oncology)
Tickers: LPTX, ELEV, ALPMY
Executed On: Jun 12, 2023 at 01:00 PM EDT
Upcoming & Overdue Catalysts (ELEV)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ELEV)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
